These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30455401)

  • 1. DRB4*01:01 Has a Distinct Motif and Presents a Proinsulin Epitope That Is Recognized in Subjects with Type 1 Diabetes.
    James EA; Gillette L; Durinovic-Bello I; Speake C; Bondinas GP; Moustakas AK; Greenbaum CJ; Papadopoulos GK; Kwok WW
    J Immunol; 2018 Dec; 201(12):3524-3533. PubMed ID: 30455401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic analysis of the combinatorial nature of epitopes recognized by TCR leads to identification of mimicry epitopes for glutamic acid decarboxylase 65-specific TCRs.
    Uemura Y; Senju S; Maenaka K; Iwai LK; Fujii S; Tabata H; Tsukamoto H; Hirata S; Chen YZ; Nishimura Y
    J Immunol; 2003 Jan; 170(2):947-60. PubMed ID: 12517961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential binding of pyruvate dehydrogenase complex-E2 epitopes by DRB1*08:01 and DRB1*11:01 Is predicted by their structural motifs and correlates with disease risk.
    Chow IT; James EA; Gates TJ; Tan V; Moustakas AK; Papadopoulos GK; Kwok WW
    J Immunol; 2013 May; 190(9):4516-24. PubMed ID: 23543758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The susceptible HLA class II alleles and their presenting epitope(s) in Goodpasture's disease.
    Xie LJ; Cui Z; Chen FJ; Pei ZY; Hu SY; Gu QH; Jia XY; Zhu L; Zhou XJ; Zhang H; Liao YH; Lai LH; Hudson BG; Zhao MH
    Immunology; 2017 Aug; 151(4):395-404. PubMed ID: 28342268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelic variation in key peptide-binding pockets discriminates between closely related diabetes-protective and diabetes-susceptible HLA-DQB1*06 alleles.
    Ettinger RA; Papadopoulos GK; Moustakas AK; Nepom GT; Kwok WW
    J Immunol; 2006 Feb; 176(3):1988-98. PubMed ID: 16424231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DR.
    van Lummel M; van Veelen PA; de Ru AH; Janssen GM; Pool J; Laban S; Joosten AM; Nikolic T; Drijfhout JW; Mearin ML; Aanstoot HJ; Peakman M; Roep BO
    J Immunol; 2016 Apr; 196(8):3253-63. PubMed ID: 26944932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosinase epitope recognized by an HLA-DR-restricted T-cell line from a Vogt-Koyanagi-Harada disease patient.
    Kobayashi H; Kokubo T; Takahashi M; Sato K; Miyokawa N; Kimura S; Kinouchi R; Katagiri M
    Immunogenetics; 1998 Apr; 47(5):398-403. PubMed ID: 9510558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predominantly recognized proinsulin T helper cell epitopes in individuals with and without islet cell autoimmunity.
    Durinovic-Belló I; Boehm BO; Ziegler AG
    J Autoimmun; 2002 Feb; 18(1):55-66. PubMed ID: 11869047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin.
    Congia M; Patel S; Cope AP; De Virgiliis S; Sønderstrup G
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3833-8. PubMed ID: 9520453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DR binding analysis of peptides from islet antigens in IDDM.
    Geluk A; van Meijgaarden KE; Schloot NC; Drijfhout JW; Ottenhoff TH; Roep BO
    Diabetes; 1998 Oct; 47(10):1594-601. PubMed ID: 9753297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in self-peptide binding between T1D-related susceptible and protective DR4 subtypes.
    Ge X; James EA; Reijonen H; Kwok WW
    J Autoimmun; 2011 Mar; 36(2):155-60. PubMed ID: 21257290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens.
    Honeyman MC; Stone NL; Falk BA; Nepom G; Harrison LC
    J Immunol; 2010 Feb; 184(4):2204-10. PubMed ID: 20083660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DR53 molecules restrict glutamic acid decarboxylase peptide presentation to T cells of a Type I diabetes patient: specification of the trimolecular HLA-peptide/T-cell receptor complex.
    Huck C; Endl J; Walk T; Noessner E; Jung G; Wank R; Schendel DJ
    Diabetologia; 2001 Jan; 44(1):70-80. PubMed ID: 11206414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: analysis in disease discordant human twins, non-obese diabetic mice and HLA-DQ transgenic mice.
    Boyton RJ; Lohmann T; Londei M; Kalbacher H; Halder T; Frater AJ; Douek DC; Leslie DG; Flavell RA; Altmann DM
    Int Immunol; 1998 Dec; 10(12):1765-76. PubMed ID: 9885897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definition of the peptide binding motif within DRB1*1401 restricted epitopes by peptide competition and structural modeling.
    James EA; Moustakas AK; Berger D; Huston L; Papadopoulos GK; Kwok WW
    Mol Immunol; 2008 May; 45(9):2651-9. PubMed ID: 18276010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA-DR(alpha1*0101,beta1*0401) transgenic mice.
    Patel SD; Cope AP; Congia M; Chen TT; Kim E; Fugger L; Wherrett D; Sonderstrup-McDevitt G
    Proc Natl Acad Sci U S A; 1997 Jul; 94(15):8082-7. PubMed ID: 9223318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of glutamic acid decarboxylase 65 peptides presented by the type I diabetes-associated HLA-DQ8 class II molecule identifies an immunogenic peptide motif.
    Herman AE; Tisch RM; Patel SD; Parry SL; Olson J; Noble JA; Cope AP; Cox B; Congia M; McDevitt2 HO
    J Immunol; 1999 Dec; 163(11):6275-82. PubMed ID: 10570321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Proinsulin T Cell Epitopes Restricted by Type 1 Diabetes-Associated HLA Class II Molecules.
    Ihantola EL; Ilmonen H; Kailaanmäki A; Rytkönen-Nissinen M; Azam A; Maillère B; Lindestam Arlehamn CS; Sette A; Motwani K; Seay HR; Brusko TM; Knip M; Veijola R; Toppari J; Ilonen J; Kinnunen T
    J Immunol; 2020 May; 204(9):2349-2359. PubMed ID: 32229538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease.
    Bach JM; Otto H; Nepom GT; Jung G; Cohen H; Timsit J; Boitard C; van Endert PM
    J Autoimmun; 1997 Aug; 10(4):375-86. PubMed ID: 9237801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proinsulin-specific, HLA-DQ8, and HLA-DQ8-transdimer-restricted CD4+ T cells infiltrate islets in type 1 diabetes.
    Pathiraja V; Kuehlich JP; Campbell PD; Krishnamurthy B; Loudovaris T; Coates PT; Brodnicki TC; O'Connell PJ; Kedzierska K; Rodda C; Bergman P; Hill E; Purcell AW; Dudek NL; Thomas HE; Kay TW; Mannering SI
    Diabetes; 2015 Jan; 64(1):172-82. PubMed ID: 25157096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.